Screening for retinopathy of prematurity (ROP) in South Africa: data from a newly established prospective regional

Tshilidzi van der Lecq1, Natasha Rhoda2, Esmè Jordaan3,4

  • 1Department of Surgery, Division of Ophthalmology, University of Cape Town, Cape Town, South Africa Tshilidzi.vanderlecq@uct.ac.za.

PubMed

Insights

Low screening coverage for retinopathy of prematurity (ROP) in South Africa may bias ROP frequency data. Improving screening rates is crucial for accurate ROP monitoring and guideline revision.

Area of Science:

  • Neonatal care
  • Ophthalmology
  • Public health

Background:

  • Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
  • Population-based registers are essential for monitoring ROP screening programs and improving outcomes.
  • The ROP South African (ROPSA) register was established to assess ROP frequency and screening coverage.

Purpose of the Study:

  • To determine the frequency of ROP and the coverage of ROP screening in a South African cohort.
  • To evaluate the effectiveness of current ROP screening programs.
  • To inform revisions of national ROP screening guidelines.

Main Methods:

  • Prospective data collection from infants born between May 2022 and January 2023 at five Cape Town NICUs.
  • Inclusion criteria: gestational age <32 weeks or birth weight <1250g.
  • Data extracted from the ROPSA register for analysis.

Main Results:

  • 696 of 1154 (60.3%) eligible infants were screened; 45.7% had incomplete screening.
  • ROP was detected in 31.6% of screened infants; 1.0% required treatment.
  • Infants with incomplete screening had significantly lower gestational age and birth weight.

Conclusions:

  • Low screening coverage and high rates of incomplete screening may bias ROP frequency data from the ROPSA register.
  • Further investigation into reasons for low screening coverage is needed.
  • Interventions to improve screening are necessary, and the ROPSA register can monitor their impact.
Abstract